J0463 HCPCS Level II code: Injection, atropine sulfate (fresenius and therapeutically equivalent), 0.01 mg
J0463 is the HCPCS code for “Injection, atropine sulfate (fresenius and therapeutically equivalent), 0.01 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J0463Injection, atropine sulfate (fresenius and therapeutically equivalent), 0.01 mg
Short description: Inj atropine (fresenius te)
HCPCS · United States
Medicare details
The indicators CMS publishes with J0463 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- Type of service
- Medical care
- BETOS category
- Other drugs
- Added
- Apr 1, 2026
Where J0463 sits
- 1J codesDrugs administered other than orally
- 2Active code J0463Injection, atropine sulfate (fresenius and therapeutically equivalent), 0.01 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J0463 mean?
J0463 is the HCPCS code for “Injection, atropine sulfate (fresenius and therapeutically equivalent), 0.01 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J0463?
CMS lists J0463’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J0463
All J codesJ0402Injection, aripiprazole (abilify asimtufii), 1 mgJ0456Injection, azithromycin, 500 mgJ0457Injection, aztreonam, 100 mgJ0458Injection, aztreonam/avibactam, 7.5 mg/2.5 mg (10 mg)J0461Injection, atropine sulfate, 0.01 mgJ0462Injection, atropine sulfate, not therapeutically equivalent to j0461, 0.01 mgJ0470Injection, dimercaprol, per 100 mgJ0475Injection, baclofen, 10 mgJ0476Injection, baclofen, 50 mcg for intrathecal trialJ0480Injection, basiliximab, 20 mgJ0485Injection, belatacept, 1 mgJ0490Injection, belimumab, 10 mg